Platelet-Activating Factor Acetylhydrolases (PAF-AH)

Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997. Dr. Diana Stafforini works at the Huntsman Cancer Institute at the University of Utah School of Medicine. Professor Inoue works at the Teikyo University, School of Pharmacy, Japan.

• Overview of PAF Degrading EnzymesKen Karasawa and Keizo Inoue Intracellular PAF Acetylhydrolase Type IMitsuharu Hattori and Hiroyuki AraiPlatelet-Activating Factor Acetyl Hydrolase and Brain DevelopmentGary D. ClarkIntracellular Platelet Activating Factor (PAF) Acetylhydrolase, Type II: A  Unique Cellular Phospholipase A2 that Hydrolyzes Oxidatively-Modified PhospholipidsNozomu Kono and Hiroyuki AraTrafficking and Oligomeric Regulation of Platelet-Activating Factor         Acetylhydrolase Type IIMeghan M. Klems and Brian J. BahnsonPlasma PAF-AH (PLA2G7): Biochemical Properties, Association with LDLs and HDLs, and Regulation of ExpressionDiana M. StafforiniCrystal Structure and Atomic Level Analysis of Plasma PAF-AH  Tara D. Gonzalez and Brian J. BahnsonNaturally Occurring Missense Mutation in Plasma PAF-AH Among the  Japanese PopulationKen KarasawaPlasma PAFAH/PLA2G7 Genetic Variability, Cardiovascular Disease and Clinical TrialsSonia Karabina and Ewa NinioDiverse Functions of Plasma PAF-AH in TumorigenesisDiana M. Stafforini